UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

SABR-Dual: a phase II/III trial of two-fraction versus five-fraction stereotactic radiotherapy for localized low- and favorable intermediate-risk prostate cancer

BMC cancer, 2024-04, Vol.24 (1), p.431-431, Article 431

2024

Volltextzugriff (PDF)

Concurrent Tumor Treating Fields (TTFields) and Radiation Therapy for Newly Diagnosed Glioblastoma: A Prospective Safety and Feasibility Study

Frontiers in oncology, 2020-04, Vol.10, p.411-411

2020

Volltextzugriff (PDF)

Assessment of laryngeal cancer in patients younger than 40 years

The Laryngoscope, 2018-07, Vol.128 (7), p.1602-1605

2018

Volltextzugriff (PDF)

Aggressive Palliation and Survival in Anaplastic Thyroid Carcinoma

JAMA otolaryngology-- head & neck surgery, 2015-12, Vol.141 (12), p.1128

2015

Volltextzugriff (PDF)

The role of a radiopaque peri-rectal hydrogel spacer in aiding accurate daily image-guidance for prostate stereotactic radiotherapy

Frontiers in oncology, 2024-06, Vol.14, p.1386058

2024

Volltextzugriff (PDF)

Same-day versus delayed simulation imaging after placement of a perirectal hydrogel spacer for prostate radiotherapy

Frontiers in oncology, 2023-07, Vol.13, p.1236113-1236113

2023

Volltextzugriff (PDF)

Role of Induction Chemotherapy Prior to Chemoradiation in Head and Neck Squamous Cell Cancer-Systematic Review and Meta-analysis

The cancer journal (Sudbury, Mass.), 2017-03, Vol.23 (2), p.79-83

2017

Volltextzugriff (PDF)

Phase II organ‐preservation trial: Concurrent cisplatin and radiotherapy for advanced laryngeal cancer after response to docetaxel, cisplatin, and 5‐fluorouracil–based induction chemotherapy

Head & neck, 2017-02, Vol.39 (2), p.227-233

2017

Volltextzugriff (PDF)

Clinical utility and treatment outcome of comprehensive genomic profiling in high grade glioma patients

Journal of neuro-oncology, 2016-10, Vol.130 (1), p.211-219

2016

Volltextzugriff (PDF)

Acute Lymphoblastic Leukemia Relapse Limited to the Anterior Chamber of the Eye and Treated with Novel CAR T-Cell Therapy

Case reports in ophthalmology, 2021-12, Vol.12 (3), p.994-1001

2021

Volltextzugriff (PDF)

Pancreatic cancer outcome-local treatment with radiation using MRI-LINAC

Frontiers in oncology, 2023, Vol.13, p.1289919-1289919

2023

Volltextzugriff (PDF)

Single fraction stereotactic radiosurgery for multiple brain metastases

Advances in radiation oncology, 2017-10, Vol.2 (4), p.555-563

2017

Volltextzugriff (PDF)

1965: Acute toxicity after SABR to the prostate and pelvic lymph nodes for high-risk prostate cancer

Radiotherapy and oncology, 2024-05, Vol.194, p.S2477-S2477

2024

Volltextzugriff (PDF)

CTIM-31. A PHASE II, OPEN-LABEL, SINGLE ARM TRIAL OF PEMBROLIZUMAB FOR REFRACTORY ATYPICAL AND ANAPLASTIC MENINGIOMA AND HEMANGIOPERICYTOMA

Neuro-oncology (Charlottesville, Va.), 2021-11, Vol.23 (Supplement_6), p.vi57-vi57

2021

Volltextzugriff (PDF)

A phase II, open-label, single-arm trial of pembrolizumab for refractory atypical and anaplastic meningioma and hemangiopericytoma

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.2064-2064

2021

Volltextzugriff (PDF)

Acute Toxicity and Early Prostate Specific Antigen Response After Two-Fraction Stereotactic Radiation Therapy for Localized Prostate Cancer Using Peri-Rectal Spacing – Initial Report of the SABR-Dual Trial

International journal of radiation oncology, biology, physics, 2024-07

2024

Volltextzugriff (PDF)

NIMG-74. COMPARING VOLUMETRIC GROWTH-RATE AND RANO CRITERIA IN DETERMINING THE RESPONSE OF MENINGIOMA TO BEVACIZUMAB THERAPY

Neuro-oncology (Charlottesville, Va.), 2023-11, Vol.25 (Supplement_5), p.v202-v203

2023

Volltextzugriff (PDF)

Abstract CT008: Tumor Treating Fields combined with radiotherapy and temzolomide for newly diagnosed glioblastoma: Final results from a pilot study

Cancer research (Chicago, Ill.), 2019-07, Vol.79 (13_Supplement), p.CT008-CT008

2019

Volltextzugriff (PDF)

UNcommon EGFR Mutations: International Case Series on Efficacy of Osimertinib in Real-Life Practice in First-LiNe Setting (UNICORN)

Journal of thoracic oncology, 2023-02, Vol.18 (2), p.169-180

2023

Volltextzugriff (PDF)

Pembrolizumab: first experience with recurrent primary central nervous system (CNS) tumors

Journal of neuro-oncology, 2016-09, Vol.129 (3), p.453-460

2016

Volltextzugriff (PDF)

Abstract CT206: Concurrent Tumor Treating Fields (TTFields) and radiation therapy for newly diagnosed glioblastoma: A safety and feasibility study

Cancer research (Chicago, Ill.), 2020-08, Vol.80 (16_Supplement), p.CT206-CT206

2020

Volltextzugriff (PDF)

Brain metastases in patients with ovarian cancer

Acta oncologica, 2022-06, Vol.61 (6), p.757-763

2022

Volltextzugriff (PDF)

Stem the blood flow: beneficial impact of bevacizumab on survival of subventricular zone glioblastoma patients

Journal of neuro-oncology, 2024-09

2024

Volltextzugriff (PDF)

Updated safety/feasibility study of concurrent tumor treating fields (TTFields) and radiation therapy for newly diagnosed glioblastoma

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.e14535-e14535

2020

Volltextzugriff (PDF)

NIMG-05. DIFFERENCES IN VASCULARITY BETWEEN RECURRENT GLIOBLASTOMA AND BRAIN METASTASIS USING DYNAMIC CONTRAST ENHANCED MRI

Neuro-oncology (Charlottesville, Va.), 2021-11, Vol.23 (Supplement_6), p.vi128-vi128

2021

Volltextzugriff (PDF)

1 – 25 von 66

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(63)
Mit Volltextzugriff
(60)

Publikationsform

Artikel
(65)
Berichte
(1)

Sprache

Englisch
(65)
Hebräisch
(1)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(5)

Menü

Weitere Dienste

Einstellungen

SABR-Dual: a phase II/III trial of two-fraction versus five-fraction stereotactic radiotherapy for localized low- and favorable intermediate-risk prostate cancer

Concurrent Tumor Treating Fields (TTFields) and Radiation Therapy for Newly Diagnosed Glioblastoma: A Prospective Safety and Feasibility Study

Assessment of laryngeal cancer in patients younger than 40 years

Aggressive Palliation and Survival in Anaplastic Thyroid Carcinoma

The role of a radiopaque peri-rectal hydrogel spacer in aiding accurate daily image-guidance for prostate stereotactic radiotherapy

Same-day versus delayed simulation imaging after placement of a perirectal hydrogel spacer for prostate radiotherapy

Role of Induction Chemotherapy Prior to Chemoradiation in Head and Neck Squamous Cell Cancer-Systematic Review and Meta-analysis

Phase II organ‐preservation trial: Concurrent cisplatin and radiotherapy for advanced laryngeal cancer after response to docetaxel, cisplatin, and 5‐fluorouracil–based induction chemotherapy

Clinical utility and treatment outcome of comprehensive genomic profiling in high grade glioma patients

Acute Lymphoblastic Leukemia Relapse Limited to the Anterior Chamber of the Eye and Treated with Novel CAR T-Cell Therapy

Pancreatic cancer outcome-local treatment with radiation using MRI-LINAC

Single fraction stereotactic radiosurgery for multiple brain metastases

1965: Acute toxicity after SABR to the prostate and pelvic lymph nodes for high-risk prostate cancer

CTIM-31. A PHASE II, OPEN-LABEL, SINGLE ARM TRIAL OF PEMBROLIZUMAB FOR REFRACTORY ATYPICAL AND ANAPLASTIC MENINGIOMA AND HEMANGIOPERICYTOMA

A phase II, open-label, single-arm trial of pembrolizumab for refractory atypical and anaplastic meningioma and hemangiopericytoma

Acute Toxicity and Early Prostate Specific Antigen Response After Two-Fraction Stereotactic Radiation Therapy for Localized Prostate Cancer Using Peri-Rectal Spacing – Initial Report of the SABR-Dual Trial

NIMG-74. COMPARING VOLUMETRIC GROWTH-RATE AND RANO CRITERIA IN DETERMINING THE RESPONSE OF MENINGIOMA TO BEVACIZUMAB THERAPY

Abstract CT008: Tumor Treating Fields combined with radiotherapy and temzolomide for newly diagnosed glioblastoma: Final results from a pilot study

UNcommon EGFR Mutations: International Case Series on Efficacy of Osimertinib in Real-Life Practice in First-LiNe Setting (UNICORN)

Pembrolizumab: first experience with recurrent primary central nervous system (CNS) tumors

Abstract CT206: Concurrent Tumor Treating Fields (TTFields) and radiation therapy for newly diagnosed glioblastoma: A safety and feasibility study

Brain metastases in patients with ovarian cancer

Stem the blood flow: beneficial impact of bevacizumab on survival of subventricular zone glioblastoma patients

Updated safety/feasibility study of concurrent tumor treating fields (TTFields) and radiation therapy for newly diagnosed glioblastoma

NIMG-05. DIFFERENCES IN VASCULARITY BETWEEN RECURRENT GLIOBLASTOMA AND BRAIN METASTASIS USING DYNAMIC CONTRAST ENHANCED MRI

Suchergebnisse filtern